[DNLI] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
08-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 35.36%
YoY- -61.93%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 4,197 4,205 125,676 1,195 1,648 641 145,149 -90.64%
PBT -58,650 -38,992 77,533 -35,371 -54,724 -23,678 -22,887 87.58%
Tax -313 0 -2,379 0 0 0 -807 -46.90%
NP -58,337 -38,992 77,533 -35,371 -54,724 -23,678 -22,887 86.91%
Tax Rate - - 3.07% - - - - -
Total Cost 62,534 43,197 48,143 36,566 56,372 24,319 168,036 -48.35%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -1,389.97 -927.28 61.69 -2,959.92 -3,320.63 -3,693.92 -15.77 1896.84%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.61 -0.41 0.82 -0.38 -0.59 -0.26 -0.74 -12.11%
EPS Diluted -0.61 -0.41 0.79 -0.38 -0.59 -0.26 -0.74 -12.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.